Acrylonitrile adducts: design, synthesis and biological evaluation as antimicrobial, haemolytic and thrombolytic agent. [PDF]
Sci Rep, 2023 Das P +6 more
europepmc +1 more source
Hemodialysis International, EarlyView.ABSTRACT Background Hemodialysis access thrombosis is the primary cause of access failure. Thrombus removal is an effective strategy to restore access function. Although both open surgical and endovascular procedures enable thrombus clearance, endovascular thrombus reduction therapy is widely adopted in clinical practice for this condition due to its ...
Lin Li +5 more
wiley +1 more source
Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute mycardial infarction receiving thrombolytic therapy [PDF]
, 1993 Objectives. This study was conducted to explore mechanisms that could explain the possible clinical benefit of early administration of a beta1-selective adrenoreceptor blocking agent or a bradycardiac drag as adjunct to thrombolysis in acute myocardial ...
Mortelmans, Luc +10 more
core +1 more source
In vitro thrombolytic potential of bioactive compounds from marine Streptomyces sp. VITJS4
Bioscience Journal, 2016 The most practical approach to reduce morbidity and mortality of coronary heart disease (CHD) is to delay the process of thrombus by usage of clot-dissolving agents. The necessities of such safer compounds are to be critically examined for thrombolyticÂ
S Jemimah Naine +2 more
doaj +3 more sources
BMC Biotechnology, 2012 Background Today, thrombosis is one of the most widely occurring diseases in modern life. Drugs with thrombolytic functions are the most effective methods in the treatment of thrombosis.
Yuan Jun +5 more
doaj +1 more source
Constitutively active ADAMTS13: An emerging thrombolytic agent for acute ischemic stroke. [PDF]
J Thromb Haemost, 2022 Nayak MK, Flora GD, Chauhan AK.
europepmc +1 more source
PLoS ONE, 2016 Streptokinase (SK) remains a favored thrombolytic agent in the developing world as compared to the nearly 10-fold more expensive human tissue-plasminogen activator (tPA) for the dissolution of pathological fibrin clots in myocardial infarction.
Pooja Sawhney, Keya Katare, Girish Sahni
doaj +1 more source
Successful thrombolysis with low dose thrombolytic agent in a patient with acute life-threatening massive pulmonary thromboembolism: A case report. [PDF]
Ann Med Surg (Lond), 2022 Adhikari S +3 more
europepmc +1 more source
Mitochondrial oxidative stress, calcium and dynamics in cardiac ischaemia‐reperfusion injury
The Journal of Physiology, EarlyView.Abstract figure legend Heart attack causes ischaemia–reperfusion injury in cardiomyocytes. Mitochondria generate reactive oxygen species (ROS), leading to oxidative stress. High levels of mitochondrial calcium (Ca2+) activate the mitochondrial permeability transition pore (mPTP), and excess ROS levels can lower the Ca2+ required to activate the mPTP ...
Emily Rozich +5 more
wiley +1 more source
Dissecting intramural hematoma of esophagus after thrombolytic therapy: A case report [PDF]
, 2015 Esophageal hematoma is a relatively rare event. We report a case of severe chest pain associated with myocardial infarction and recurrent chest pain after administration of a thrombolytic agent.
Chehrehgosha, H. +5 more
core